These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17023870)

  • 41. No significant association between genetic variants in 7 candidate genes and response to methylphenidate treatment in adult patients with ADHD.
    Contini V; Victor MM; Bertuzzi GP; Salgado CA; Picon FA; Grevet EH; Rohde LA; Belmonte-de-Abreu P; Bau CH
    J Clin Psychopharmacol; 2012 Dec; 32(6):820-3. PubMed ID: 23131881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
    Palumbo DR; Sallee FR; Pelham WE; Bukstein OG; Daviss WB; McDERMOTT MP;
    J Am Acad Child Adolesc Psychiatry; 2008 Feb; 47(2):180-188. PubMed ID: 18182963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder.
    Biederman J; Quinn D; Weiss M; Markabi S; Weidenman M; Edson K; Karlsson G; Pohlmann H; Wigal S
    Paediatr Drugs; 2003; 5(12):833-41. PubMed ID: 14658924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Familial Correlation in Methylphenidate Response and Side Effect Profile.
    Gazer-Snitovsky M; Brand-Gothelf A; Dubnov-Raz G; Weizman A; Gothelf D
    J Atten Disord; 2019 Jan; 23(2):135-139. PubMed ID: 25899797
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.
    Turner DC; Blackwell AD; Dowson JH; McLean A; Sahakian BJ
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):286-95. PubMed ID: 15338103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD.
    Pearson DA; Santos CW; Roache JD; Casat CD; Loveland KA; Lachar D; Lane DM; Faria LP; Cleveland LA
    J Am Acad Child Adolesc Psychiatry; 2003 Feb; 42(2):209-16. PubMed ID: 12544181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.
    Reimherr FW; Williams ED; Strong RE; Mestas R; Soni P; Marchant BK
    J Clin Psychiatry; 2007 Jan; 68(1):93-101. PubMed ID: 17284136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of children with Williams syndrome with methylphenidate.
    Bawden HN; MacDonald GW; Shea S
    J Child Neurol; 1997 Jun; 12(4):248-52. PubMed ID: 9203066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD.
    Lee J; Grizenko N; Bhat V; Sengupta S; Polotskaia A; Joober R
    BMC Psychiatry; 2011 Apr; 11():70. PubMed ID: 21510895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD.
    Thakur GA; Grizenko N; Sengupta SM; Schmitz N; Joober R
    BMC Psychiatry; 2010 Jun; 10():50. PubMed ID: 20569447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.
    Pagerols M; Richarte V; Sánchez-Mora C; Garcia-Martínez I; Corrales M; Corominas M; Cormand B; Casas M; Ribasés M; Ramos-Quiroga JA
    Pharmacogenomics J; 2017 Jan; 17(1):98-104. PubMed ID: 26810137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
    Pelham WE; Gnagy EM; Burrows-Maclean L; Williams A; Fabiano GA; Morrisey SM; Chronis AM; Forehand GL; Nguyen CA; Hoffman MT; Lock TM; Fielbelkorn K; Coles EK; Panahon CJ; Steiner RL; Meichenbaum DL; Onyango AN; Morse GD
    Pediatrics; 2001 Jun; 107(6):E105. PubMed ID: 11389303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
    Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
    CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.